New Guidelines Recommend LAMA as First-Line Bronchodilator for COPD: Respiratory Society

Prof. Masakazu Ichinose The Japanese Respiratory Society (JRS) recommends long-acting muscarinic antagonists (LAMAs) as long-acting bronchodilators in first-line treatment of chronic obstructive pulmonary disease (COPD) during the stable period. The JRS’s new guidelines for the diagnosis and treatment of COPD,...read more